ClinicalTrials.Veeva

Menu

ComparIson of Strategies to PrepAre SeveRely CALCified Coronary Lesions 2 (ISAR-CALC2)

G

German Heart Center Munich

Status

Enrolling

Conditions

Calcified Coronary Artery Disease

Treatments

Device: Super High Pressure Balloon (OPN NC)
Device: Intravascular lithotripsy (IVL)

Study type

Interventional

Funder types

Other
Industry

Identifiers

NCT05072730
GE IDE Nr. BA00421

Details and patient eligibility

About

The ISAR-CALC 2 trial is an investigator-initiated, prospective, randomized, multicenter, assessors-blind, open-label other clinical investigation. The objective of this trial is to investigate final angiographic minimal lumen diameter (MLD) following a strategy of super high-pressure balloon (OPN NC) versus intravascular lithotripsy (IVL) for drug-eluting stent (DES) implantation in severely calcified coronary lesions.

Full description

Detailed information is provided elsewhere.

Enrollment

80 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Age above 18 years and able to give consent
  • Persistent angina despite medical therapy and/or evidence of inducible ischemia
  • De-novo lesion in a native coronary artery
  • Target reference vessel diameter or intended stent diameter ≥2.50 or ≤4.00 mm by visual estimation
  • Severe calcification of the target lesion as determined by visual estimation at coronary angiography
  • Unsuccessful lesion preparation with standard non-compliant balloon (< 30% reduction of baseline diameter stenosis at maximal pressure)
  • Written informed consent.

Exclusion criteria

  • Target lesion is located in a coronary artery bypass graft
  • Target lesion is an in-stent restenosis
  • Target lesion is a chronic total occlusion
  • Target vessel thrombus
  • Limited long-term prognosis due to other comorbid conditions with life expectancy <12 months

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

80 participants in 2 patient groups

Super high-pressure balloon (OPN NC)
Experimental group
Description:
Patients will be treated with a Super High Pressure percutaneous transluminal coronary angioplasty (PTCA) Balloon (OPN NC).
Treatment:
Device: Super High Pressure Balloon (OPN NC)
Intravascular lithotripsy (IVL)
Experimental group
Description:
Patients will be treated with intravascular lithotripsy (IVL).
Treatment:
Device: Intravascular lithotripsy (IVL)

Trial contacts and locations

4

Loading...

Central trial contact

Tobias Rheude, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems